Condition
Endometrial Cancer Stage IV
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed1
Terminated1
Not Yet Recruiting1
Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07189702Not ApplicableNot Yet Recruiting
Plant-Based Nutrition for Breast or Endometrial Cancer
NCT03339765Not ApplicableCompleted
Self-Advocacy Serious Game in Advanced Cancer
NCT03642990Phase 2Terminated
NR in Chemo-induced Peripheral Neuropathy
NCT03621904Recruiting
PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer
Showing all 4 trials